Phase II Study [resa]    
Systemic Chemotherapy [topp]    
Advance [qlco]    
Unresectable [clna]    
hepatobiliary [bdsy]    
Carcinoma [neop]    
Background [cnce]    
Aim [idcn]    
patient [podg]    
Advance [qlco]    
Unresectable [clna]    
hepatobiliary [bdsy]    
Carcinoma [neop]    
Prognosis [hlca]    
Efficacy [qlco]    
Systemic Chemotherapy [topp]    
patient [podg]    
Negligible [qlco]    
Often [tmco]    
patient [podg]    
Hepatocellular carcinoma [neop]    
toxic [qlco]    
Chemotherapies [topp]    
Potential [qlco]    
Palliative [qlco]    
Effect [qlco]    
New [tmco]    
Agent [chvf]    
Mild [qlco]    
toxic [qlco]    
Profile [lbpr]    
Activate [dora]    
solid tumor [neop]    
investigate [ftcn]    
Effect [qlco]    
patient [podg]    
Advance [qlco]    
Hepatocellular [qlco]    
Cholangiocellular Carcinoma [neop]    
Phase II Study [resa]    
Three [qnco]    
patient [podg]    
Cholangiocellular Carcinoma [neop]    
patient [podg]    
Hepatocellular carcinoma [neop]    
studies [mnob]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Liver Cirrhosis [dsyn]    
Administer [ftcn]    
Once weekly [tmco]    
3 Weeks [tmco]    
Consecutive [qlco]    
4 Weeks [tmco]    
patient [podg]    
Cholangiocellular Carcinoma [neop]    
Receive [qlco]    
week [tmco]    
First [qnco]    
Cycle [tmco]    
Rest [dora]    
Following [tmco]    
Cycle [tmco]    
Disease [dsyn]    
Status [qlco]    
Assess [acty]    
4 Weeks [tmco]    
Result [ftcn]    
Overall [inpr]    
Regimen [topp]    
Well [qlco]    
median [spco]    
*Number [qnco]    
Administration [ocac]    
Ranges [qnco]    
<3 [qnco]    
Group [idcn]    
patient [podg]    
Cholangiocellular Carcinoma [neop]    
Ranges [qnco]    
<3 [qnco]    
Group [idcn]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Group [idcn]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Thrombocytopenia [fndg]    
Most [qnco]    
Frequent [tmco]    
Side Effect [patf]    
Grade 4 [qlco]    
patient [podg]    
Cholangiocellular Carcinoma [neop]    
Nausea [sosy]    
Neutropenia [fndg]    
Most [qnco]    
Observation [ftcn]    
Side Effect [ftcn]    
Overall Response [fndg]    
Rate [acty]    
Hepatocellular carcinoma [neop]    
Only [qnco]    
Chemotherapies [topp]    
Not [ftcn]    
Tumor [neop]    
Symptom [ftcn]    
patient [podg]    
Group [idcn]    
Contrast [qlco]    
Group [idcn]    
Cholangiocellular Carcinoma [neop]    
Seven [qnco]    
patient [podg]    
partial response [fndg]    
Overall Response [fndg]    
Rate [acty]    
Eleven [qnco]    
patient [podg]    
Cholangiocellular Carcinoma [neop]    
reveal [qlco]    
Tumor [neop]    
Symptom [ftcn]    
Onset [qlco]    
treatment [ftcn]    
Seven [qnco]    
patient [podg]    
treatment [ftcn]    
Relate [orch]    
Clinical [qlco]    
Benefit [qnco]    
Defined [cnce]    
Relief [fndg]    
Tumor [neop]    
Symptom [ftcn]    
Gain [qnco]    
weight [orga]    
Conclusion [idcn]    
Result [ftcn]    
treatment [ftcn]    
Cholangiocarcinoma [neop]    
Effect [qlco]    
Further [spco]    
Evaluable [ftcn]    
Phase III Study [resa]    
Contrast [qlco]    
Palliative [qlco]    
Chemotherapies [topp]    
recommend [idcn]    
patient [podg]    
Hepatocellular carcinoma [neop]    
Liver Cirrhosis [dsyn]    
